Alwan, A., MacLean, D.R., Riley, L.M., d’Espaignet, E.T., Mathers, C.D., Stevens, G.A., et al. (2010) Monitoring and Surveillance of Chronic Non-Communicable Diseases: Progress and Capacity in High-Burden Countries. The Lancet, 376, 1861-1868.
http://dx.doi.org/10.1016/S0140-6736(10)61853-3

has been cited by the following article:

• TITLE: National Breast Cancer Mortality and Incidence Rates According to the Human Development Index: An Ecological Study

  AUTHORS: Salman Khazaei, Shahab Rezaeian, Zaher Khazaei, Leila Molaeipoor, Shahrzad Nematollahi, Parvaneh Lak, Somayeh Khazaei

  KEYWORDS: Breast Cancer, Human Development Index, Incidence, Age-Standardized Incidence and Mortality Rates

  JOURNAL NAME: Advances in Breast Cancer Research, Vol.5 No.1, January 27, 2016

  ABSTRACT: Background: This study aimed to identify the role of human development index (HDI) in the incidence and mortality rates of breast cancer (BC) worldwide. Methods: Data on the age-standardized incidence and mortality rates of BC for 184 countries were obtained from the GLOBOCAN. Data about the HDI and other indices were obtained from the World Bank Report 2013. Linear regression model was used for assessment the effect of HDI on BC occurrence rates. Results: In 2012, BCs were estimated to have affected a total of 1,671,149 individuals (crude rate: 47.8 per 100,000 individuals), and caused 521,907 deaths worldwide (crude rate: 14.7 per 100,000 individuals). Nearly half of total female BC cases (46.3%) with the highest risk of incidence (age-standardized Rate (ASR): 128 per 100,000) had occurred in very high HDI regions. The most proportion of the mortality burden was in low HDI and medium HDI areas. Linear regression analyses showed a direct significant correlation between the incidence of BC and HDI at the global level (B = 104.5, P